In 2012, Cattell was diagnosed with cancer and was treated with an experimental drug developed by colleagues at University of Minnesota's Masonic Cancer Center. After receiving an increased dosage of an experimental drug there was a reduction in Cattell's tumor and her lymphoma was considered in remission.